SEC Form 6-K filed by SOPHiA GENETICS SA
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO
RULE 13a-16 OR 15d-16 UNDER THE SECURITIES
EXCHANGE ACT OF 1934
For the month of June 2024.
Commission File Number: 001-40627
SOPHiA GENETICS SA
(Exact name of registrant as specified in its charter)
La Pièce 12
CH-1180 Rolle
Switzerland
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
Form 20-F | x | Form 40-F |
SOPHiA GENETICS SA (the “Company”) today published its Environmental, Social and Governance Impact Summary as per December 31, 2023 (“2023 ESG Impact Summary”). The 2023 ESG Impact Summary is available on www.sophiagenetics.com, in the Investor Relations section.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
SOPHiA GENETICS SA |
Date: June 7, 2024 | ||
By: | /s/ Daan van Well | |
Name: | Daan van Well | |
Title: | Chief Legal Officer |
EXHIBIT INDEX | |||
Exhibit No. | Description | ||
99.1 | 2023 ESG Impact Summary |